NEDD4L and hydrops fetalis: For example, NEDD4 was found to predict adverse cardiovascular outcomes in PEAR clinical trial (136), and miR-454/NEDD4-2/TrkA/cAMP axis was demonstrated to exert anti-apoptosis effects and improves HF in rats, thus potentially laying the foundation for clinical trials.